Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoquefort Thera Share News (ROQ)

Share Price Information for Roquefort Thera (ROQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.65
Bid: 4.50
Ask: 4.80
Change: 0.00 (0.00%)
Spread: 0.30 (6.667%)
Open: 4.65
High: 4.65
Low: 4.65
Prev. Close: 4.65

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

20 Jun 2024 15:48

UK shareholder meetings calendar - next 7 days

Friday 21 June 
All Things Considered Group PLCAGM
Monday 24 June 
Anglo-Eastern Plantations PLCAGM
Cizzle Biotechnology Holdngs PLCAGM
Cobra Resources PLCAGM
Diaceutics PLCAGM
Ithaca Energy PLCAGM
Network International Holdings PLCAGM
Oriole Resources PLCAGM
Oxford Biomedica PLCAGM
Savannah Resources PLCAGM
THG PLCAGM
Trinity Exploration & Production PLCAGM
World Chess PLCAGM
Tuesday 25 June 
Alphawave IP Group PLCAGM
Anpario PLCAGM
Aurrigo International PLCAGM
Elixirr International PLCAGM
Future Metals NLGM
Gemfields Group LtdAGM
Huddled Group PLCAGM
ICG Enterprise Trust PLCAGM
IQE PLCAGM
Roadside Real Estate PLCAGM
Rockhopper Exploration PLCAGM
Saga PLCAGM
Skillcast Group PLCAGM
Verici Dx PLCAGM
Vertu Motors PLCAGM
Vietnam Enterprise Investments LtdAGM
Xeros Technology Group PLCAGM
Wednesday 26 June 
Amicorp FS UK PLCAGM
Ariana Resources PLCGM re merger with Rockover Holdings
Asiamet Resources LtdAGM
Avacta Group PLCAGM
Bluejay Mining PLCAGM
Cora Gold LtdAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
East Star Resources PLCAGM
Echo Energy PLCAGM
Emmerson PLCAGM
HSS Hire Group PLCAGM
India Capital Growth Fund LtdAGM
Infrastructure India PLCGM re delisting from AIM
International Consolidated Airlines Group SAAGM
Novacyt SAAGM
Pinewood Technologies Group PLCAGM
RA International Group PLCAGM
SpaceandPeople PLCAGM
Warpaint London PLCAGM
Thursday 27 June 
Adnams PLCAGM
Aminex PLCAGM
Afentra PLCAGM
Atalaya Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Caspian Sunrise PLCAGM
CMO Group PLCAGM
Crimson Tide PLCAGM
Directa Plus PLCAGM
DP Poland PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
Genflow Biosciences PLCAGM
GENinCode PLCAGM
Getech Group PLCAGM
Hamak Gold LtdAGM
Hemogenyx Pharmaceuticals PLCAGM
Hydrogen Utopia International PLCAGM
i3 Energy PLCAGM
JD Sports Fashion PLCAGM
Kanabo Group PLCAGM
NAHL Group PLCAGM
Next 15 Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
Sivota PLCAGM
URA Holdings PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
23 May 2024 21:25

TRADING UPDATES: Windward wins deal; Kodal progresses at Bougouni

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
26 Apr 2024 20:59

EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
5 Apr 2024 12:32

IN BRIEF: Roquefort cancels fundraise after "unusual" stock movements

Roquefort Therapeutics PLC - London-based biotechnology company - Says it has opted against a fundraise following "unusual share price movements". The company had engaged advisers to commence "market soundings" in relation to a potential placing, but says that "incorrect bulletin board comments regarding a speculative placing price," which in turn impacted its share price, turned it against the idea. Shares in Roquefort dropped 36% on Thursday from 6.89 pence each to 4.41 pence, having hovered around the 7p mark for the whole of March.

Read more
11 Mar 2024 11:12

Roquefort celebrates "significant milestones" in cancer research

(Alliance News) - Roquefort Therapeutics PLC on Monday reported progress in cancer research under two of its medicine development programmes.

Read more
6 Feb 2024 16:50

IN BRIEF: Roquefort hails further MK studies, licence talks continue

Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Says it has continued studies on its MK cells in validated models of natural killer (NK) cell activation and cytotoxicity, showing an anti-cancer effect in leukaemia with superior efficacy to NK cells alone. Confirms that MK cells activate NK cells.

Read more
6 Nov 2023 12:01

Roquefort Therapeutics MK cell programme shows positive results

(Alliance News) - Roquefort Therapeutics PLC on Monday said its Mesodermal Killer cell programme has reached a "significant" milestone.

Read more
27 Sep 2023 15:43

EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
14 Aug 2023 11:07

Roquefort files patent application for mRNA and RNA therapies

(Alliance News) - Roquefort Therapeutics PLC on Monday said it has filed an international phase PCT patent for its anti-cancer mRNA and RNA oligonucleotide therapies.

Read more
7 Aug 2023 11:04

IN BRIEF: Roquefort announces new sirNA sequences and patent filing

Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Announces the development of new small interfering ribonucleic acid sequences. Says sequences expand its portfolio of siRNA medicines, which it purchased through its acquisition of London-based cancer medications company Oncogeni Ltd in September. Adds it has completed a new patent filing to strengthen its siRNA patent pisition. Says the sequences are being developed alongside nano-particle delivery systems to target hard-to-treat, high mortality solid cancers. Results are expected in the fourth quarter of 2023.

Read more
29 Jun 2023 18:51

TRADING UPDATES: Anpario trading in line, Likewise Group sales rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 20:34

TRADING UPDATES: Plant Health Care announces GBP2.8 million fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 12:28

Roquefort Therapeutics celebrates cancer antibody trial results

(Alliance News) - Roquefort Therapeutics PLC on Monday said its recent in vivo study targeting midkine-expressing cancers has shown "significant" success by its lead antibody programmes, which its CEO said "demonstrate the potential for a best-in-class medicine."

Read more
13 Jun 2023 11:52

IN BRIEF: Roquefort says anti-cancer mRNA study shows positive results

Roquefort Therapeutics PLC - London-based biotech company focused on developing medicines for hard-to-treat cancers - Says recently completed in vitro studies for new messenger ribonucleic acid therapeutic show "statistically significant reduction" in proliferation and migration of breast and liver cancer. Study was part of Roquefort's new anti-cancer mRNA therapeutics platform focused on the Midkine growth target. The MDK mRNA programme was tested in validated in vitro cancer models to evaluate effect on growth and migration. Roquefort acknowledges that these are early results but says therapeutic shows potential to become first-in-class cancer treatment if they are replicated in clinical trials. It recently updated its filed patents to protect MDK mRNA programme compositions and methods. Programme now will move to in vivo studies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.